Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 310 institutions that hold shares in the stock, with a total of 200 Million shares, which have been reported (via 13F filing form) to have a value of $1.42 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
21,790,881
shares
|
$154 Million
0.0% of portfolio
|
Q3 2025
Added 6.07%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
19,956,255
shares
|
$141 Million
0.0% of portfolio
|
Q2 2024
Added 8.22%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
12,169,000
shares
|
$86.2 Million
1.72% of portfolio
|
Q3 2025
Added 159.36%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
9,807,438
shares
|
$69.4 Million
0.0% of portfolio
|
Q3 2025
Added 15.31%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
9,390,270
shares
|
$66.5 Million
6.02% of portfolio
|
Q3 2025
Added 10.95%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
5,967,737
shares
|
$42.3 Million
0.01% of portfolio
|
Q3 2025
Added 6.29%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
5,464,021
shares
|
$38.7 Million
0.06% of portfolio
|
Q3 2025
Reduced 4.38%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,286,536
shares
|
$37.4 Million
0.04% of portfolio
|
Q2 2023
Reduced 5.91%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
5,225,986
shares
|
$37 Million
0.03% of portfolio
|
Q3 2025
Added 22.14%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
5,202,959
shares
|
$36.8 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.38%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
5,052,307
shares
|
$35.8 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.05%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
4,419,629
shares
|
$31.3 Million
0.06% of portfolio
|
Q3 2025
Added 3.06%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
4,240,712
shares
|
$30 Million
0.07% of portfolio
|
Q3 2025
Added 0.29%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Nov 14, 2025 Q3 2025 |
3,620,261
shares
|
$25.6 Million
0.37% of portfolio
|
Q3 2025
Added 191.03%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
3,617,882
shares
|
$25.6 Million
0.01% of portfolio
|
Q3 2025
Added 2.36%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,419,046
shares
|
$24.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 28.99%
|
|
|
Assenagon Asset Management S.A.
|
Oct 07, 2025 Q3 2025 |
3,092,592
shares
|
$21.9 Million
0.04% of portfolio
|
Q3 2025
Reduced 14.58%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
2,711,806
shares
|
$19.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 23.05%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2025 Q3 2025 |
2,632,696
shares
|
$18.6 Million
0.01% of portfolio
|
Q3 2025
Reduced 5.38%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
2,410,362
shares
|
$17.1 Million
0.02% of portfolio
|
Q3 2025
Added 1.55%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
2,197,765
shares
|
$15.6 Million
0.15% of portfolio
|
Q3 2025
Reduced 16.23%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
2,140,534
shares
|
$15.2 Million
0.02% of portfolio
|
Q3 2025
Reduced 15.28%
|
|
|
Jupiter Asset Management LTD
|
Nov 10, 2025 Q3 2025 |
2,055,915
shares
|
$14.6 Million
0.14% of portfolio
|
Q3 2025
Reduced 1.06%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
1,994,404
shares
|
$14.1 Million
0.0% of portfolio
|
Q3 2025
Added 1.25%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
1,902,819
shares
|
$13.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 33.03%
|
|